Waters Corporation (WAT)

NYSE: WAT · Real-Time Price · USD

344.82

-5.67 (-1.62%)

May 8, 2026, 11:09 AM EDT - Market open

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Apr '26 Apr 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Waters Instrument Systems Revenue	-	1.10B	1.03B
Waters Instrument Systems Revenue Growth	-	6.72%	-6.87%
Chemistry Consumables Revenue	-	631.46M	565.48M
Chemistry Consumables Revenue Growth	-	11.67%	4.44%
TA Instrument Systems Revenue	-	243.82M	246.20M
TA Instrument Systems Revenue Growth	-	-0.97%	-2.64%
Total Product Sales Revenue	2.50B	1.98B	1.84B
Total Product Sales Revenue Growth	26.22%	7.21%	-3.09%
Waters Service Revenue	-	1.08B	1.01B
Waters Service Revenue Growth	-	7.32%	5.78%
TA Service Revenue	-	108.02M	107.76M
TA Service Revenue Growth	-	0.24%	5.71%
Total Service Sales Revenue	1.28B	1.19B	1.11B
Total Service Sales Revenue Growth	7.31%	6.64%	5.78%
Revenue (Other)	-	-3.17B	-2.96B
Revenue (Total)	3.77B	3.17B	2.96B
Revenue (Total) Growth	19.12%	6.99%	0.07%

Revenue Breakdown 3

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Apr '26 Apr 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Pharmaceutical Revenue	-	1.87B	1.72B
Pharmaceutical Revenue Growth	-	8.99%	1.30%
Industrial Revenue	-	961.15M	908.49M
Industrial Revenue Growth	-	5.80%	-0.06%
Academic and Governmental Revenue	-	330.77M	331.00M
Academic and Governmental Revenue Growth	-	-0.07%	-5.57%
Revenue (Total)	3.77B	3.17B	2.96B
Revenue (Total) Growth	19.12%	6.99%	0.07%

Updated May 5, 2026. Data Source: Fiscal.ai.